JP2019513814A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513814A5
JP2019513814A5 JP2018555644A JP2018555644A JP2019513814A5 JP 2019513814 A5 JP2019513814 A5 JP 2019513814A5 JP 2018555644 A JP2018555644 A JP 2018555644A JP 2018555644 A JP2018555644 A JP 2018555644A JP 2019513814 A5 JP2019513814 A5 JP 2019513814A5
Authority
JP
Japan
Prior art keywords
leucine
acetyl
acceptable salt
pharmaceutically acceptable
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018555644A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513814A (ja
JP7387264B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2017/051090 external-priority patent/WO2017182802A1/en
Publication of JP2019513814A publication Critical patent/JP2019513814A/ja
Priority to JP2021185130A priority Critical patent/JP7506046B2/ja
Publication of JP2019513814A5 publication Critical patent/JP2019513814A5/ja
Application granted granted Critical
Publication of JP7387264B2 publication Critical patent/JP7387264B2/ja
Priority to JP2024096260A priority patent/JP2024123087A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018555644A 2016-04-19 2017-04-19 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩 Active JP7387264B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021185130A JP7506046B2 (ja) 2016-04-19 2021-11-12 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩
JP2024096260A JP2024123087A (ja) 2016-04-19 2024-06-13 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1606834.8 2016-04-19
GB201606834 2016-04-19
PCT/GB2017/051090 WO2017182802A1 (en) 2016-04-19 2017-04-19 Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021185130A Division JP7506046B2 (ja) 2016-04-19 2021-11-12 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩

Publications (3)

Publication Number Publication Date
JP2019513814A JP2019513814A (ja) 2019-05-30
JP2019513814A5 true JP2019513814A5 (https=) 2022-01-21
JP7387264B2 JP7387264B2 (ja) 2023-11-28

Family

ID=58633040

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018555644A Active JP7387264B2 (ja) 2016-04-19 2017-04-19 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩
JP2021185130A Active JP7506046B2 (ja) 2016-04-19 2021-11-12 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩
JP2024096260A Pending JP2024123087A (ja) 2016-04-19 2024-06-13 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021185130A Active JP7506046B2 (ja) 2016-04-19 2021-11-12 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩
JP2024096260A Pending JP2024123087A (ja) 2016-04-19 2024-06-13 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩

Country Status (26)

Country Link
US (4) US10905670B2 (https=)
EP (2) EP3445351B1 (https=)
JP (3) JP7387264B2 (https=)
KR (4) KR102632670B1 (https=)
CN (2) CN118593463A (https=)
AU (2) AU2017252507B2 (https=)
BR (1) BR112018071547A2 (https=)
CA (1) CA3021155A1 (https=)
DK (1) DK3445351T3 (https=)
ES (1) ES2994242T3 (https=)
FI (1) FI3445351T3 (https=)
HR (1) HRP20241552T1 (https=)
HU (1) HUE069219T2 (https=)
IL (3) IL262379B (https=)
LT (1) LT3445351T (https=)
MD (1) MD3445351T2 (https=)
MX (2) MX388461B (https=)
PL (1) PL3445351T3 (https=)
PT (1) PT3445351T (https=)
RS (1) RS66142B1 (https=)
RU (1) RU2745912C2 (https=)
SG (2) SG11201809031XA (https=)
SI (1) SI3445351T1 (https=)
SM (1) SMT202400459T1 (https=)
WO (1) WO2017182802A1 (https=)
ZA (1) ZA201806849B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2994242T3 (en) * 2016-04-19 2025-02-05 Intrabio Ltd Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility
WO2018029658A1 (en) 2016-08-11 2018-02-15 Intrabio Limited Therapeutic agents for neurodegenerative diseases
GB201709459D0 (en) 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
EP3886986A1 (en) 2018-12-06 2021-10-06 IntraBio Ltd Deuterated analogs of acetyl-leucine
SMT202400334T1 (it) * 2019-03-02 2024-09-16 Intrabio Ltd (n-)acetil-l-leucina per il trattamento di lesioni cerebrali traumatiche
US20250099355A1 (en) * 2023-07-18 2025-03-27 Sytheon Ltd Amino acid based salts, compositions and methods for treating skin and improving skin rejuvenation and longevity
US12403111B2 (en) 2024-02-02 2025-09-02 SynGAP Research Fund Compositions and methods for treating neurodevelopmental disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
US20070190070A1 (en) * 2004-09-03 2007-08-16 Zeldis Jerome B Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
FR2883180B1 (fr) * 2005-03-18 2007-05-25 Pierre Fabre Medicament Sa Utilisation de l'acetyl-leucine pour la preparation d'un medicament destine au traitement de troubles de l'equilibre
FR2905600B1 (fr) * 2006-09-13 2010-01-15 Pf Medicament Traitement des vertiges par l'acetyl-l-leucine.
US20080097606A1 (en) * 2006-10-19 2008-04-24 Cragg Andrew H Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis
WO2008134844A1 (en) * 2007-05-08 2008-11-13 Multi Formulations Ltd. Branched-chain amino acid composition for improving skeletal muscle protein metabolism
WO2011025518A1 (en) * 2009-08-27 2011-03-03 Albert Einstein College Of Medicine Of Yeshiva University Cognitive function training to improve motor ability
TN2010000251A1 (fr) * 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
WO2012060844A1 (en) * 2010-11-05 2012-05-10 Biotie Therapies, Inc A2a antagonists as cognition and motor function enhancers
TN2010000566A1 (en) * 2010-12-03 2012-05-24 Rekik Raouf Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs
ES2994242T3 (en) * 2016-04-19 2025-02-05 Intrabio Ltd Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility
US12458614B2 (en) * 2017-10-18 2025-11-04 Intrabio Ltd Therapeutic agents for improved mobility and cognitive function and for treating neurodegenerative diseases and lysosomal storage disorders

Similar Documents

Publication Publication Date Title
JP2019513814A5 (https=)
JP6466540B2 (ja) 多発性硬化症を治療するためのＰＰＡＲγアゴニスト
US11083735B2 (en) Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions
US20230146896A1 (en) Composition and method for treating alzheimer's disease
AU2017277005B2 (en) Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
JP2009537553A5 (https=)
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
JP2012197304A (ja) ミオパシー関連性の覚醒障害を矯正することが意図される医薬品を製造するためのモダフィニルの使用
JP2023500032A5 (https=)
CN107835695A (zh) 用于治疗自闭症的组合物和方法
US20180221315A1 (en) Combination therapy using acamprosate and d-cycloserine
WO2007046347A1 (ja) 筋萎縮性側索硬化症患者の運動神経保護用医薬
IL272834B2 (en) Amantadine compositions, preparations thereof, and methods of use
JP2021530568A5 (https=)
JP2022526643A5 (https=)
KR102693607B1 (ko) 하지 불안 증후군을 치료하기 위한 치료제
RU2391095C1 (ru) Фармацевтическая композиция, включающая холина альфосцерат и гопантеновую кислоту (или ее соль), для лечения недостаточности кровообращения мозга и эректильной дисфункции
EP4420660A1 (en) Use of edaravone in treatment of autism spectrum disorder
JP2008535907A5 (https=)
CA2330568A1 (en) Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
RU2002115814A (ru) Лечение системной красной волчанки с помощью дегидроэпиандростерона
US20160367503A1 (en) Combination Medication for Neuro-Degenerative Diseases
RU2345778C1 (ru) Способ лечения расстройств эрекции у мужчин
RS63859B1 (sr) N,n-bis-2-merkaptoetil izoftalamid za lečenje neurodegenerativnih bolesti
JP2025501458A5 (https=)